Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling study

BACKGROUND: As of the end of 2021, twenty-four countries in the African meningitis belt have rolled out mass campaigns of MenAfriVac®, a meningococcal A conjugate vaccine (MACV) first introduced in 2010. Twelve have completed introduction of MACV into routine immunisation (RI) schedules. Although se...

Descripción completa

Detalles Bibliográficos
Autores principales: Bender, Rose G., Shen, Jasmine, Aravkin, Aleksandr, Bita Fouda, André Arsène, Bwaka, Ado M., Galles, Natalie C., Haeuser, Emily, Hay, Simon I., Latt, Anderson, Mwenda, Jason M., Rogowski, Emma L.B., Sbarra, Alyssa N., Sorensen, Reed J.D., Vongpradith, Avina, Wright, Claire, Zheng, Peng, Mosser, Jonathan F., Kyu, Hmwe H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985031/
https://www.ncbi.nlm.nih.gov/pubmed/36880052
http://dx.doi.org/10.1016/j.eclinm.2022.101797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985031/
https://www.ncbi.nlm.nih.gov/pubmed/36880052
http://dx.doi.org/10.1016/j.eclinm.2022.101797

Ejemplares similares